Introduction
A ll-trans retinoic acid (RA), a derivative of vitamin A, is one of the most powerful morphogens governing the development of various tissues and organs, including the central nervous system. RA has been reported to regulate neuron formation both in the embryonic, as well as in the postnatal/adult brain [1] [2] [3] [4] and has been widely used as a potent inducer of neuronal differentiation in various multipotent cell populations (embryonic carcinoma cells, embryonic and neural stem cells, induced pluripotent stem cells), in vitro.
The major molecular mechanisms that control RA availability and signaling were thoroughly characterized over the last decades [5] [6] [7] [8] [9] . In brief, extracellular retinol (ROL) is delivered to the tissues via ROL binding protein 4 (RBP4), which associates with the transthyretin carrier in the circulation (Fig. 1) . ROL can be taken up by cells via facilitated transport upon RBP4-ROL binding to the STRA6 transporter [10] . Once within the cell, ROL can either be stored after conversion to retinyl esters (RE) by lecithin retinol acyltransferase (LRAT, [11] ) or it can be directed towards RA synthesis. In the latter case, ROL is reversibly converted to retinaldehyde (RAL) by ROL/alcohol dehydrogenases (RDHs/ADHs), among which RDH10 seems to play a primary role [12, 13] . RAL is irreversibly oxidized to all-trans RA by RALDH1-3 retinaldehyde dehydrogenases, while RALDH4 was shown to be involved in the biosynthesis of 9-cis RA [14] . Oxidation of RA into polar metabolites is mediated by CYP26 hydroxylases, a family of cytochrome P450 enzymes. RA exerts most of its effects through activation of nuclear retinoid receptors, the heterodimers of the RA receptor (RAR) and the retinoid X receptor (RXR) [8] . All-trans RA activates RARs and 9-cis RA binds to both RARs and RXRs [15] . The activated nuclear receptor dimers attach to RA response elements (RAREs) in the promoter regions of target genes [8, 15, 16] . Because of the multiplicity of responsive genes and interacting transcription factors, the actual actions of RA highly depend on the type, as well as the physiological and developmental stage of the target cells.
During development, RA plays important regulatory roles in the formation of the neural tube and regional patterning of the future hindbrain and spinal cord [1] . Morphogenic roles of retinoids were also demonstrated in the developing forebrain [17] [18] [19] and the presence and production of RA was described in a subdivision of the developing rostro-ventral telencephalon, the lateral ganglionic eminence [19] [20] [21] . RAresponsive cells persist in the main neural stem cell niches of the postnatal rodent brain, including the subventricular zone (SVZ) adjacent to the lateral ventricles and the dentate gyrus of the hippocampal formation [2] [3] [4] [22] [23] [24] . Depletion of RA in adult mice was shown to result in significantly decreased neuronal differentiation within the dentate gyrus [25, 26] and RA synthesis seems to regulate proliferation and gene transcription of at least a subset of neural stem cells in the SVZ [27, 28] . Most likely, RA signaling can determine the fate of resident neural stem cells throughout life. However, despite the accumulating knowledge on RA's action, the contribution of intracerebral production and distribution of retinoids to the genesis and renewal of neural tissue still needs to be specified.
The aim of the present work was to investigate the retinoid sensitivity of distinct neural stem/progenitor populations and to map the expression of retinoid metabolism related genes during their in vitro neuronal differentiation. For this purpose, neural stem cells cloned from early embryonic (E9) mouse neuroectoderm (NE-4C cells; [29] [30] [31] [32] [33] [34] ) and stem/progenitor cells isolated from late embryonic (E14.5) or adult (P62) neurogenic zones (RGl cells; [35] ) were used. The results demonstrated that the investigated stem/ progenitor populations showed significant differences in many aspects of both RA metabolism and retinoid responsiveness. Each neural stem cell population generated bioactive retinoids capable of activating the RARE-lacZ reporter transgene from precursor (RE, ROL) molecules, while the initiation of neuronal differentiation via RA signaling was restricted to NE-4C neural stem cells.
Materials and Methods

NE-4C neuroectodermal stem cells
NE-4C cells (ATCC no.: CRL-2925; [32] ) derived from the anterior brain vesicles of p53 deficient 9 day old mouse embryos were maintained in serum containing medium, composed of minimum essential medium (MEM; SigmaAldrich) supplemented with 5% fetal calf serum (FCS; Invitrogen-Gibco), 4 mM glutamine (Sigma-Aldrich) and 40 mg/mL gentamycin (Chinoin), at 37°C temperature with 5% CO 2 . For maintenance, subconfluent cultures were regularly split by trypsinization (0.05 w/v% trypsin in PBS) into poly-L-lysine-coated Petri dishes. Neural differentiation was induced either by addition of RA/ROL/RE (see Results) or by changing the maintenance medium to defined medium (DM), formulated as MEM/F12 [1:1] supplemented with insulin-transferrin-selenite cocktail (Invitrogen-Gibco).
Radial glia-like cells
Radial glia like (RGl) cells were isolated from late embryonic/fetal (E14,5-16) or adult (P50-180) mouse brains via selective attachment to adhesive surfaces covered with FIG. 1. Retinoid metabolism. In the circulation, ROL is bound to RBP4. It can be taken up by cells by facilitated transport via STRA6 receptors. Within the cell, ROL is carried by CRBPs and can be stored in the form of REs or converted to RA in a two step process. RA is transported to the nucleus upon binding to CRABPs and acts through the activation of RA receptor heterodimers. Excess RA can be metabolized by the CYP26 enzymes. RE, retinyl ester; RAL, retinaldehyde; ROL, retinol; RA, retinoic acid; RBP4, retinol binding protein 4; STRA6, receptor for the ROL/RBP4 complex; CRBP, cellular ROL binding protein; CRABP, cellular RA binding protein; ADH, alcohol dehydrogenase; RDH, ROL dehydrogenase; RALDH, retinaldehyde dehydrogenase; REH, retinyl ester hydrolase; LRAT, lecithin ROL acyltransferase; RAR, RA receptor; RXR, retinoid X receptor; CYP26, a family of cytochrome P450 (CYP) enzymes.
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AK-cyclo[RGDfC] peptides [36] , as described previously [35] . The RGl clones used in the presented experiments were prepared either from late embryonic (E14.5) forebrains (RGl-1 and A2 clones) or from the SVZ (SVZ_M clone) or hippocampus (HC_A clone) of adult (P62) mouse brain [35] . The cells were maintained in DM composed of DMEM/F12 [1:1] (Sigma-Aldrich), 1% (v/v) B27 (Invitrogen-Gibco) and 20 ng/mL epidermal growth factor (EGF) (Peprotech) (EGF + ). According to the aim of the experiment, B27 supplement without (DM) or with retinyl acetate (DM+ RE) [37, 38] was used. For large-scale neuron-production, EGF was withdrawn (EGF -) from the media of confluent cultures of RGl cells.
Treatment with retinoids and RAR antagonist
Neural stem cells were treated for varying periods with various concentrations of retinoids according to the actual experimental design. NE-4C cells collected for RT-PCR or real-time PCR were treated with 100 nM all-trans RA (SigmaAldrich) for an initial 48 h. In other experiments retinoids in 100 nM-10 mM concentrations were applied for 48 h or on every 2nd day. The pan RAR antagonist AGN193109 (Allergan, Inc.) was applied daily, at a final concentration of 100 nM [24] . In experiments using retinoids, the cultures and samples were protected from light.
RA reporter bioassay
The level of biologically active retinoids was determined by RA reporter cells as described previously [24] . In brief, F9 embryonic carcinoma cells, carrying a RARE-lacZ construct [39] were maintained in DMEM containing 10% FCS, in the presence of 400 mg/mL G418 (Sigma-Aldrich). F9 cells, plated 24 h before the onset of the experiments in 50,000 cell/cm 2 density, were treated with media conditioned by stem cells for 24 h. In other experiments, F9 cells were seeded on top of confluent layers of neural stem cells to detect the actual retinoid production. After 18 h, the cultures were homogenized and the b-galactosidase activity of the homogenates was determined by the chromogenic substrate ortho-nitrophenyl-b-D-galactopyranoside (Sigma-Aldrich). The optical density was measured at a wavelength of 420 nm. The data were related to optical densities of retinoid-free cultures of the reporter cells (100%) and averages and standard deviations of relative values (as percentages) were calculated from 6-8 assays. Student's t-test was used to calculate the P-values.
In experiments with NE-4C cells, the culture media were changed to defined media either lacking retinoids (DM) or supplemented with 1 mM ROL, RE or RA for the initial 48 h of differentiation. After induction, the cultures were washed several times with retinoid free DM and were subjected to the F9 reporter assay on the 8th day. In agreement with published data [40] and our tests (not shown), RA used in the 48 h induction period was successfully removed by the media changes and/or degraded within no more than 4 days.
RGl cells were maintained in DM supplemented either with retinoid free or retinyl acetate supplemented B27 for 2 weeks before the F9 bioassays. Then the cells were differentiated by EGF removal and conditioned media were collected on the 7th day of induction.
Immunocytochemical staining and evaluation of neuron number
Cultures were fixed with 4% paraformaldehyde in PBS at room temperature for 20 min. Before staining, the cells were treated with 0.1% Triton X-100 in PBS for 5 min. After permeabilization, nonspecific antibody binding was blocked by incubating with 5% FCS in PBS (PBS-FCS) for 1.5 h at room temperature. Primary antibodies were diluted in PBS-FCS and were used at 4°C, overnight. Monoclonal antibodies against neuron-specific b-III tubulin or GFAP (Sigma-Aldrich) were diluted in 1:2,000. For fluorescent detection, Alexa-488 and Alexa-594 conjugated secondary antibodies (Invitrogen) were used at 1:1,000 dilutions, for 60 min at room temperature. Independent experimental series and subsequent immunostainings were performed at least four times. The analysis of the images (15 image/culture, 10 · objective, Zeiss Axiovert 200M microscope) was performed by using AxioVision 4.8 and ImageJ softwares. As an alternative approach, the number of neurons (b-III tubulin positive cells) and the total number of DAPI stained nuclei were manually counted on 15 images taken from each of four parallel cultures grown in the presence or absence of retinoids or RAR antagonist for 4 days. The percentages of neurons were calculated for each culture, and were averaged among identical treatment-groups. Averages and standard deviations were related to those obtained from retinoid free, control cultures. Student's t-test was used to calculate the P-values.
Microarray
Samples were collected from noninduced or RA-induced NE-4C cells being at the 1st, 3rd, 6th and 10th day of differentiation. The cells were grown in the standard MEM medium complemented with 5% FCS. The RNA integrity was checked with Agilent 2100 Bioanalyzer. The generation of cDNA, production of labeled cRNA, and hybridization to Agilent G4120A Mouse Development Microarrays were performed according to standard protocols provided by the manufacturer at the Microarray Core Facility at the Department of Genetics, Celland Immunobiology at Semmelweis University (Budapest, Hungary). All materials were purchased from Agilent (Agilent Technologies) except RNA isolation kit (Qiagen).
RT-PCR analysis
Total RNA was isolated from cells with Tri Reagent (SigmaAldrich) according to the manufacturer's protocol. DNA contamination was eliminated by DNase-I (Fermentas) treatment and RNA fraction was dissolved in RNase/DNase free water at a concentration of 1 mg/mL. Reverse transcription reactions were undertaken from 3 mg total RNA using First Strand cDNA Synthesis Kit (Fermentas). The quantity of the cDNA product was determined by PCR (Hotstart Taq PCR Kit; Qiagen) using the hypoxanthine phosphoribosyltransferase 1 (Hprt1) coding gene. For each primer pair (see table below), the PCR conditions (temperatures, cycle numbers and MgCl 2 concentration) have been optimized. The PCR products were analysed by electrophoresis on agarose gel with ethidium bromide, and were visualized by UV trans-illumination.
The presented RT-PCR results are representatives of several independent experiments. In NE-4C cells five completely different series, while in the case of RGl cells six independent 
RNA isolation for real-time PCR
Total RNA was isolated using RNAzol RT solution (Molecular Research Center Inch.) according to the manufacturer's protocol. Although intron-spanning primer pairs (see table below) were used in the Real-Time PCR experiments, genomic DNA contamination was regularly checked by Real-Time PCR using ACTB (beta-actin) primers on 100 ng total RNA templates. The RNA samples were considered to be free of genomic DNA contamination, when C T -s was higher, than cycle 35. To remove DNA contamination, recombinant DNase treatment was carried out using rDNase set (Macherey-Nagel) then the samples were subsequently cleaned and concentrated using NucleoSpin RNA Clean-up XS kit (Macherey-Nagel) according to the manufacturer's protocol. The quantity and quality of the RNA were checked by spectrophotometry and gel electrophoresis.
Target
Primer sequence CC Amplicon (nt) 
Reverse transcription for real-time PCR
Briefly 2 mg total RNA, 200 ng Random Primers (Invitrogen, Life Technologies), and 1 mL dNTP (10 mM each) were combined and incubated for 5 min at 65°C. After 2 min chilling on ice, 200 U SuperScript III Reverse Transcriptase (Invitrogen, Life Technologies), 40 U RNaseOUT Recombinant Ribonuclease Inhibitor (Invitrogen, Life Technologies), and 5 mM dithiothreitol were added to the mixture in 20 mL reaction volume. The reaction mixture was incubated at 25°C for 10 min to anneal the random hexamers, at 50°C for 5 h to transcribe cDNA and at 70°C for 15 min to inactivate the enzymes.
Relative quantitative real-time PCR assay 1 mL cDNA was used for quantifying mRNA together with 300 or 900 nM intron-spanning primers and 10 mL 2 · Power Syber Green PCR Master Mix (Applied Biosystems). Each reaction was run in triplicate on differentiating NE-4C (DIV2, 4, 6, 10, 14) , embryonic RGl or adult RGl (DIV4, DIV8) samples, as well as on nondifferentiated NE-4C or RGl (DIV0) samples. Amplification was performed in StepOnePlus (Applied Biosystems) equipment.
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Real-time PCR data evaluation
Data were normalized to hypoxanthine phosphoribosyltransferase 1 (Hprt1) gene expression and evaluated with StepOne Software v2.1 (Applied Biosystems) utilizing the Relative Quantitative Real-Time PCR assay evaluation with comparative C T (DDC T ) method. The Relative Quantity values were analyzed with one-way analysis of variance together with the two-sided Dunnett post-hoc test to evaluate whether difference in mRNA levels of the given target between a sample and the reference of means is significant. The statistics were carried out using the SPSS for Windows 9.0 software. On the diagrams gene expression data of differentiating and undifferentiated stem cells are compared. All data are presented as Means -SD of the biological parallels and P-values below 0.1 are shown. Detailed statistical analysis is shown in Supplementary Table S1 ; Supplementary Data are available online at www.liebertpub.com/scd
Results
Retinoid-reponsiveness and the expression of retinoid metabolism ( Fig. 1 ) related genes were investigated in different neural stem cell populations cloned from embryonic or adult brain tissues (Table 1 ) and in their progenies at various stages of in vitro induced neuronal differentiation.
NE-4C neuroectodermal stem cells ( Fig. 2A) were derived from the anterior brain vesicles of E9 mouse embryos [32] . These cells display many characteristics of radial neurepithelial cells, residents of the neural plate and early neural tube, including Oct4 and Sox2 expression, the lack of Pax6 or proneuronal/ neurogenic (Ngn2/Math2) gene transcription, and the lack of RC2 or GFAP protein production ( Fig. 2B and Table 1) . If induced by all-trans RA, NE-4C cells develop into neurons and glial cells through well characterized stages of differentiation, including transient states of radial glia like development characterized with Pax6 and Emx2 expression and RC2-immunopositivity [29, 33, 41, 42] . Mature neurons with synapsin expression and specific machinery for neurotransmitter production, release and uptake develop by the 9-10th day after RA induction [31] .
Smaller-scale neuronal differentiation of NE-4C cells was observed in the absence of exogenous RA too, in response to growth factor/serum withdrawal. Under such conditions, however, lesser neurons were formed as it was indicated by the markedly lower percentage of bIII-tubulin immunreactive cells (5.5% -1% neurons in serum withdrawal induced cultures versus 25.9% -1.5% in RA treated cultures) at DIV4. The difference in neuronal density was more evident by DIV9 ( Fig. 2A ) and was further supported by RT-PCR and real-time PCR data on Ngn2 and Math2 expression in a longer (14 day) time scale ( Fig. 2B-D Undifferentiated NE-4C cells display many embryonic stem cell features (Oct4, Nanog) with complete inactivity of tissue-specifying bHLH (Ngn2, Mash1, Math2) or radial glia specifying (Pax6, RC2) markers [32, 57, 58] . Their neural commitment is indicated by the expression of Sox2 [59] and by the fact that they could develop exclusively to neural cell types [60] . The lack of Oct4 and Nanog and the presence of RGl (RC2, GLAST) immunoreactivities together with the expression of proneural bHLH (Ngn and Mash1) genes indicate that noninduced RGl cells represent a more advanced progenitor state than NE-4C cells [35] .
*Differentiation of NE-4C cells towards the oligodendroglial lineage was observed upon implantation into the lesioned cerebral cortex [61] . Fig. S1 ). While transcription of both Ngn2 and Math2 was upregulated upon serum withdrawal, Ngn2 expression increased with a delay and Math2 expression remained below the levels observed in RA-induced cultures. Without RA, transcription of the stem cell specific Oct4 was preserved in the cultures during the entire course of differentiation showing only a minor decline, after DIV6 (Fig. 2C) . During RA-induced differentiation Oct4 expression dropped considerably by DIV6 (Fig. 2B, D) followed by a later rise back to the basal levels by DIV14. The data are in accord with our previous findings [34] on the persistence of noncommitted stem cells in differentiating cultures. Upon RA-priming, NE-4C stem cells generate neurons and the gliogenesis is blocked for a 10-12 day period [29] . By the end of the 2nd week of RA-induction, neurogenesis ceases and astrocytes appear. Without RA-priming, however, GFAP-immunpositive astrocytes are not generated at all [29] . The earlier observations together with the recent data on Gfap expression (Fig. 2C, D) indicate that neuronal differentiation dominates over gliogenesis in the investigated period of NE-4C cell development.
RGl neural stem/progenitor clones were isolated by their preferential adhesion to a synthetic polypeptide AKc(RGDfC) [36] and by propagation on peptide-coated surfaces under serum-free conditions with EGF supplementation [35] . Regardless of the age (eg, E14.5 or P62) and the region of the source brain tissue, peptide-adhering cells displayed elongated morphology (Fig. 2E) , RC2 immunoreactivity and expressed Sox2 and Pax6 mRNAs, but did not transcribe the early pluripotency genes Oct4 and Nanog [35] (Fig. 2F) . They gave rise to Ngn2 and Math2 mRNAs (Fig. 2G, H ) and bIII-tubulin (Fig. 2E ) expressing neurons upon induction by EGF withdrawal, in the absence of exogenous RA ( [35] ). Gfap mRNA was present in both embryonic and adult derived RGls cells (Fig. 2F) but GFAP protein could be demonstrated only in adult derived cultures [35] . Upon EGF withdrawal, the increase of Gfap level was significantly higher in adult RGl cells than in embryonic ones (Fig. 2G, H) .
RA-production by NE-4C neural stem cells and RGl progenitors
As we reported earlier [24] , nondifferentiated NE-4C cells did not produce enough retinoids to activate RA-reporter F9 cells. However, if neuronal differentiation was induced by an initial 48 h treatment with RA, the cells generated bioactive retinoids 6 days later, as it was indicated by the RA-reporter assay (Fig. 3A) . RA production, on the other hand, was not detected if neural differentiation was initiated by serum withdrawal without RA-treatment.
In contrast to NE-4C cells, nondifferentiated (EGF + ) RGl cells produced sufficient retinoids to be detected by F9 RAreporter cells (Fig. 3B) . Cells differentiated upon EGF removal (EGF -, DIV7) produced even higher amounts of RA, both in embryonic and adult-derived cultures. The potential for retinoid production, however, seemed to depend on RE supply in the culture medium.
The different RA production and RA-sensitivity of NE-4C and RGl cells suggested major differences in their retinoid machinery. To explore this, we investigated the transcription of genes encoding enzymes, transporters and storage proteins involved in RA metabolism in both noninduced neural stem cells and in their differentiating progenies (Table 2 and see details below).
Expression of elements of the retinoid machinery in NE-4C cells and RGl cells and in their differentiating progenies
Uptake and storage of vitamin A. The mRNA of ROL binding protein (Rbp4), the major extracellular carrier of ROL [43] was present both in NE-4C and RGl cells, regardless of the stage of differentiation (Fig. 4A, F) . The transcript of the RBP4 receptor Stra6 [10] was present in nondifferentiated NE-4C neural stem cells (Fig. 4A) . Its expression increased significantly in response to RA treatment by DIV1-2 (Fig. 4A,  B, D) , and decreased thereafter, but remained elevated in comparison to noninduced cells, even 10 days after the removal of RA (Fig. 4B) . Smaller, but significant increase was observed in Stra6 expression during serum-deprivation induced differentiation too, but with a few day delay (Fig. 4A,  B) . The Stra6 transcript was absent from or was expressed at a very low level in RGl cells (Fig. 4F) and was upregulated appreciably only in differentiating adult RGl clones (Fig. 4G, I ). 
THE RETINOID MACHINERY IN NEURAL STEM CELLS
Lrat, the major enzyme responsible for the esterification and storage of ROL, was transcribed by NE-4C neural stem cells at all stages of differentiation (Fig. 4A) . In the course of NE-4C cell differentiation its expression showed a minor and transient decrease in RA-induced cultures, while only a minor and transient elevation was observed under serum free conditions (Fig. 4A, C, E) . Lrat expression in RGl cells was around the detection limit and showed only a small decrease in embryonic and a small increase in adult RGl cells upon differentiation (Fig. 4F, H, J) .
RA synthesis. RA synthesis depends on the presence of ROL/alcohol (RDHs/ADHs) and RALDHs (Fig. 1) catalyzing the first and second steps of ROL4RAL/RA conversion, respectively. ROL dehydrogenase 10 (Rdh10), a prominent member of the Rdh family [12, 13] , was present at the mRNA level in both noninduced and differentiated neural stem cells regardless of their origin (Fig. 5A, F) . Its expression increased upon induction in NE-4C cell cultures (Fig. 5A) . In noncommitted NE-4C cells, only Raldh3 and Raldh4 mRNAs were detected, as it was shown by RT-PCR ( Fig. 5E; [24] ). During differentiation, Raldh1 displayed the highest elevations in expression among Raldhs as it is indicated by the real-time PCR data (Fig. 5B-D) . Raldh1 and also Raldh2 messages were rapidly upregulated (within 24-28 h) upon RA treatment followed by a transient decline by DIV6 or DIV4, respectively (Fig. 5B, C, E) . Raldh3 did not respond to RA treatment with an immediate upregulation but it was slightly increased during differentiation (Fig. 5D) , while Raldh4 mRNA content was slightly elevated during RA induced differentiation according to the RT-PCR data (Fig. 5E) . Under serum free conditions, Raldh1 levels increased considerably, with a peak at DIV6 (Fig. 5B) , while Raldh2 and Raldh3 levels decreased slightly during the 1st week of differentiation and increased thereafter (Fig. 5C, D) .
Raldh1 and Raldh3 mRNAs were present in nondifferentiated RGl cells, while Raldh2 was absent or expressed at a very low level (Fig. 5F ). Real-time PCR data indicated a slight increase in Raldh1 and Raldh2 expression in the adult-derived RGl cells, while both Raldh1 and Raldh2 levels dropped by DIV8 in the differentiating embryonic RGl cells (Fig. 5G, H) . A significant downregulation of Raldh3 upon EGF withdrawal was detected in all investigated RGl cell clones (Fig. 5F-H) and Raldh4 was not found in RGl cells by RT-PCR (Fig. 5F ).
The expression patterns of Raldhs were in accordance with our earlier [24, 29] and recent findings that noncommitted and differentiating neural stem cells possess the capability to produce RA.
Intracellular ROL and RA binding proteins. Cellular ROL binding protein I (CrbpI) mRNA levels increased in NE-4C neural stem cells after RA exposure, with no apparent changes in later stages of differentiation. CrbpI level was, however, not elevated in cultures induced by serum deprivation (Fig. 6A) . CrbpI mRNA was present in undifferentiated RGl cells (Fig. 6B) too. With the advancement of neural differentiation, the expression decreased in RGl cells of embryonic origin, while no marked changes were observed in adult derived cells.
In noncommitted NE-4C cells, CrabpI mRNA was not expressed, while CrabpII mRNA was present. The mRNA levels e, embryonic; a, adult.
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of both binding proteins increased after RA treatment with CrabpI responding more slowly to RA priming and declining markedly after DIV8 (Fig. 6A) . Both CrabpI and II mRNAs were expressed in all RGl clones at a relatively low level (Fig. 6B) . RA catabolism. Members of the cytochrome P450 family 26 (Cyp26) enzymes are responsible for metabolizing RA (Fig. 1) . RA treatment of NE-4C cells resulted in a marked upregulation of Cyp26a1 and Cyp26b1 mRNAs within 12 h and a moderate increase of Cyp26c1 within 24 h after RA exposure (Fig. 7A, C) . The initial elevations in all Cyp26 mRNA expressions, however, were transient and after varying periods turned to a decline. A transient but significant rise of Cyp26a1 mRNA was observed in NE-4C cells differentiating without exogenous RA too, with a peak at DIV6 (Fig. 7A, B) . The latter finding may suggest that these cells produced sufficient amounts of RA to activate the transcription of the direct RA-responsive Cyp26a1 gene. Alternatively, upregulation of the Cyp26a1 enzyme mRNA might be explained by turning on some unidentified, RAindependent and/or developmental stage-related pathways.
In embryonic RGl cells a low level Cyp26b1 expression was observed, while none of the Cyp26 enzymes could be detected in adult derived RGl clones by RT-PCR (Fig. 7D) . 
THE RETINOID MACHINERY IN NEURAL STEM CELLS
By real-time PCR, low level activation of Cyp26a1 was revealed during the differentiation of adult-derived RGl cells (Fig. 7E, F) .
RA receptors. Multiple RAR and RXR subunits were expressed by both NE-4C and RGl cells (Fig. 8A, C) . Rarb mRNA level, however, was extremely low in nondifferentiated NE-4C neural stem cells (Fig. 8A) and Rxrc mRNA was missing from all RGl cell populations (Fig. 8C) . EGF withdrawal-induced differentiation of the RGl cells was not accompanied by consistent changes in the expression of retinoid receptors, when several clones were investigated (from which Fig. 8C represents only one embryonic and one adult clone). In NE-4C cells, however, the Rarb message increased rapidly (within 12 h, data not shown) in response to 
induction regardless whether it was initiated with RA or serum deprivation, as it was shown both by RT-PCR (Fig.  8A ) and microarray data (Fig. 8B) . Rarb expression declined considerably in later stages of serum withdrawal (Fig. 8A ) and slightly during RA induced (Fig. 8A, B) differentiation.
Responsiveness of neural stem cells to RA-precursor molecules, ROL and retinyl acetate ROL induces robust neuronal differentiation in NE-4C neural stem cells. As genes encoding the components of the uptake and storage of vitamin A and the key enzymes of RA synthesis were active in noninduced NE-4C cells, we raised the question whether RA can be replaced by RA precursors in inducing neural differentiation. ROL or retinyl-acetate (RE) was added to the cells and neuron formation was followed by immunocytochemical staining for neuron-specific b-III tubulin on the 3rd, 5th, 7th, and 9th days after retinoid addition (Fig. 9A, B) . b-III tubulin immunoreactive neurons appeared in RA-primed cultures as early as the 3rd day of induction. Large scale neuron formation in ROL treated cultures was observed from the 5th day on. In RE treated or retinoid free cultures massive neuron formation was detected not sooner than the 7-9th days (Fig. 9A) , but the neuron density did not reach the levels observed in RA or ROL treated cultures (Fig. 9B) . Counting b-III tubulin immunopositive neurons revealed that all investigated retinoids significantly elevated the neuron number if applied for 4 days. Compared to retinoid free control cultures (100% -19%), the percentage of neurons was 159% -24% in RE, 179% -29% in ROL and 499% -29% in RA treated cultures (Fig. 9C) . Neuron forming effects of all retinoids were completely prevented if the pan RAR antagonist AGN193109 was included in the culture media during the 1st day of induction demonstrating that the induction was mediated through nuclear retinoid receptors regardless if it was initiated by RA, ROL, or RE. The antagonist was effective in the initial 48 h period of retinoid application, but did not arrest neuron formation if applied later (Fig. 9C) .
The schedule of differentiation was monitored also by real time PCR and RT-PCR analysis of differentiation marker gene expression (Supplementary Fig. S1 ). Real-time PCR data showed an order of DM + RA > DM + ROL > DM + RE > DM in both the magnitude and timing of the activation of proneural Ngn2 and neurogenic/neuronal Math2 genes ( Supplementary Fig. S1 ). The statistical analysis of the data revealed, that RE induced cells express significantly more Ngn2 (P < 0.005) at DIV2 and Math2 mRNAs (P < 0.005) at DIV4 than cells differentiating in retinoid free DM, indicating that RE, probably through conversion to RA, had an influence on gene expression too, even if the increase in neuron number in RE containing medium lagged behind that of 
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ROL. The induction of neuronal differentiation by different retinoids was concentration-dependent. RA initiated neuronal differentiation effectively in a concentration as low as 1 pM when applied under serum free conditions [24] , while ROL and RE induced neuron formation in 100 nM and 1 mM doses, respectively ( Supplementary Fig. S2 ). Higher concentrations resulted in formation of more compact aggregates with higher neuron density ( Supplementary Fig. S2A ). Application of RA precursors evoked changes in the expression of genes of the retinoid machinery too. Raldh1 and Stra6 mRNAs were significantly upregulated in the presence of ROL (Supplementary Fig. S1 ). The expression of Cyp26 enzymes, known to be directly regulated by RA [44] , was increased by both ROL and RE. In RE containing medium the peak of Cyp26a1 mRNA expression was at DIV6, while in ROL or RA around DIV4 and DIV2, respectively (Supplementary Fig. S1 ; Fig. 7A, C) . Rarb, another direct RAresponse gene [45, 46] showed similar quick activation in response to ROL, RE (Supplementary Fig. S1 ) and RA (Fig. 8A) .
While the cellular responses to ROL (and RE) indicated an effective conversion of the precursor molecules to active retinoids, significant retinoid-activity in the fluid environment of RE or ROL treated NE-4C cells could not be detected by the F9 RARE-lacZ reporter cell line (Fig. 3A) . These data, however, did not exclude the possibility that ROL-or RE-induced NE-4C cells produced small amounts of RA sufficient to initiate neuronal differentiation but this amount of RA, if dissolved in the large volume of culture medium, is below the detection limit (1 nM, [24] ) of the reporter assay. This assumption was supported by the fact that the RAR-antagonist AGN193109 could effectively block the ROL-induced differentiation even in a concentration as low as 100 pM ( Supplementary Fig. S2B ).
RGl cells do not differentiate in response to retinoids. To investigate the influence of retinoids on neuronal differentiation of RGl cells, we treated the cultures with 1 mM RE, ROL, or RA. In the presence of EGF, neuronal differentiation could not to be initiated by any of the retinoids as it was demonstrated by the complete lack of b-III tubulin expression (Fig. 9D) . Besides, in RGl cell cultures differentiating in response to EGF withdrawal, the percentage of neurons was not altered by either retinoid or RAR antagonist treatment (Fig. 9D-F) . Meantime, significant retinoid production by both embryonic and adult derived RGl cells was detected with F9 RA-reporter cells (Fig. 3B) .
In experiments presented in Fig. 9D -F, RGl cells were maintained in retinoid-free medium for at least 2 weeks before addition of exogenous retinoids. Retinoid depletion, however, did not affect the neurogenic capacity of the cells. These findings were further supported by experiments, when RGl cells isolated from adult brains (P153, SVZ) were prepared and maintained in DM lacking retinoids for more than 2 month. The neurogenic capacity of these cells was maintained under such conditions too (data not shown). These observations together with the inability of the pan RAR antagonist AGN193109 to prevent neuronal differentiation (Fig.  9E, F) demonstrated that endogenous RA synthesis did not contribute to enhanced neurogenesis in RGl cells.
Discussion
A number of recent investigations have demonstrated that RA-responsive cells are present not only in the developing rodent brain but they also persist in the neural stem cell niches in the postnatal CNS [2, 3, [22] [23] [24] . Retinoids are known to regulate many aspects of neural cell development, including regional and phenotype-determination [47] , gliogenesis [29] , neurite growth [48] , and synaptic functions [49] . Discussing the influence of retinoids on finetuning of neural cell type specification is beyond the scope of this article. The presented data, however, clearly indicate that distinct neural stem cell/progenitor populations respond to retinoids in diverse ways. The major similarities and differences between the investigated NE-4C and RGl stem cell populations in the context of their developmental potential, retinoid responsivity and metabolism are summarized in Tables 1-3 .
In NE-4C cells, despite of hardly measurable levels of RA production, ROL and RE initiated differentiation and activated RA-responsive (Cyp26a1, Rarb [44] [45] [46] ) genes. Delays in neuron formation and gene activation suggested a rather slow accumulation of active retinoids upon RE/ROLinduction. Even low (picomolar) levels of RA, however, can initiate neural development of NE-4C cells [24] , similarly to ES cells [47] . The lack of catabolising Cyp26 enzymes might contribute to high RA-responsiveness of noninduced NE-4C cells. During differentiation, Cyp26 enzymes are upregulated, but while balancing the intrinsic RA level, they may generate 4-oxo-and 4-hydroxy-RA compounds, known to contribute to the differentiation of ES [50] and neural progenitor [51] cells.
In contrast to NE-4C stem cells, RGl cells produced significant amounts of RA, but displayed RA-independent differentiation program. The rate of neuronal differentiation of these cells was not affected either by the application of retinoids or RAR-antagonist. Also, RGl cells, which were prepared and maintained for several weeks in retinoid free (Fig. 3, Fig. 9 , Supplementary Fig. S1 ) ii Expression of ROL/RA binding (Rbp4, CrbpI, CrabpII) and RA synthesizing protein (Rdh10 and Raldh) mRNAs (Fig. 4, Fig. 5, Fig. 6 ) iii
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conditions, could undergo neuronal differentiation upon EGF removal. The RA-production by RGl cells, however, seemed to depend on exogenous retinoid resources, which may be explained by the lack of Lrat expression resulting in a missing capacity to transform retinoids to the stored RE form. The lack or very low level expression of the ROL transporter Stra6 mRNA in RGl cells suggested the involvement of alternative retinoid uptake mechanisms [52, 53] . Interestingly, mRNA for the extracellular ROL carrier (Rbp4) was present in both NE-4C and RGl cells regardless of the stage of their development. Rbp4 expression may contribute to the regulation of vitamin A availability in the proximate environment of neural stem/progenitor cells [27, 28] or developing/mature neurons [43, 54] . Both retinoid sensitivity and production by differentiating neural stem cells highly depend on the cellular composition of the cultures. In NE-4C cells, glial differentiation was negligible in the investigated period [29] . Accordingly, the presented data reflect mainly the features of neuronal progenies of NE-4C cells. However, in RGl cells, the contribution of glial cells to the observed changes in both RA production and the retinoid machinery has to be taken into account. In mammals, many adult neural stem cells belong to GFAP-positive populations [55, 56] , and our adult-derived RGl clones also show GFAPimmunoreactivity [35] . Infinite serum-free, EGF-dependent proliferation, spindle-shaped morphology and ready neuron formation upon EGF withdrawal distinguishes RGl cells from mature astrocytes. GFAP-positive, flattened astrocytes; however, appear in differentiated cultures of both embryonic and adult RGl cells [35] . Their contribution to the retinoid metabolism can hardly be assessed. Differences in Gfap expression, in the level of RA production together with opposite changes in Stra6, Lrat, Raldh1 and Raldh2 expressions show a nonidentical cellular composition of differentiating cultures of embryonic and adult-derived RGl cells.
Our results presented here outline distinct features of retinoid metabolism in different neural stem cell populations. The highly retinoid-sensitive NE-4C neural stem cells can run the complete retinoid machinery and seem to regulate their own differentiation via autocrine or cell-autonomous RA signalling. The high sensitivity and low endogenous RA-levels, however, imply that small disturbances in extracellular retinoid supply or intrinsic RA metabolism can modulate cell-fate determining processes. As a contrast, the high RA-production of RGl cells is disconnected from immediate cell-fate decisions. The role and developmental significance of active retinoids generated by these cells are to be determined.
